Skip to main content

PFIZER INC

For the period ended Dec 31, 2023. Filed Feb 22, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 22, 2024

PFE$29.36+0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Balance Sheets

Consolidated Balance Sheets

As of December 31,
(MILLIONS, EXCEPT PER SHARE DATA)20232022
Assets
Cash and cash equivalents$2,853$416
Short-term investments9,83722,316
Trade accounts receivable, less allowance for doubtful accounts: 2023—$470; 2022—$44911,17710,952
Inventories10,1898,981
Current tax assets3,9783,577
Other current assets5,2995,017
Total current assets43,33351,259
Equity-method investments11,63711,033
Long-term investments3,7314,036
Property, plant and equipment18,94016,274
Identifiable intangible assets64,90043,370
Goodwill67,78351,375
Noncurrent deferred tax assets and other noncurrent tax assets3,7066,693
Other noncurrent assets12,47113,163
Total assets$226,501$197,205
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2023—$2,254; 2022—$2,560$10,350$2,945
Trade accounts payable6,7106,809
Dividends payable2,3722,303
Income taxes payable2,3491,587
Accrued compensation and related items2,7763,407
Deferred revenues2,7002,520
Other current liabilities20,53722,568
Total current liabilities47,79442,138
Long-term debt61,53832,884
Pension and postretirement benefit obligations2,1672,250
Noncurrent deferred tax liabilities6401,023
Other taxes payable8,5349,812
Other noncurrent liabilities16,53913,180
Total liabilities137,213101,288
Commitments and Contingencies
Preferred stock, no par value, at stated value; 27 shares authorized; no shares issued or outstanding as of December 31, 2023 and December 31, 2022——
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2023—9,562; 2022—9,519478476
Additional paid-in capital92,63191,802
Treasury stock, shares at cost: 2023—3,916; 2022—3,903(114,487)(113,969)
Retained earnings118,353125,656
Accumulated other comprehensive loss(7,961)(8,304)
Total Pfizer Inc. shareholders’ equity89,01495,661
Equity attributable to noncontrolling interests274256
Total equity89,28895,916
Total liabilities and equity$226,501$197,205
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.